REDWOOD CITY, Calif.–(BUSINESS WIRE)–May. 14, 2013–
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company
overview at the 2013 UBS Global Healthcare Conference on Monday, May 20,
2013 at 3:00 p.m. ET in New York City.
A live webcast and replay will be available on the Investors section of
the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical
production. Codexis’ proven technology enables scale-up and
implementation of biocatalytic solutions to meet customer needs for
rapid, cost-effective and sustainable process development – from
research to manufacturing. For more information, see www.codexis.com.
Source: Codexis, Inc.
Paul Cox, 212-362-1200
Connor, +44 161 359 3255